Cerebras Systems is in the spotlight this morning as the AI chipmaker makes its long-awaited debut on Nasdaq under the ticker symbol CBRS.

The company priced its IPO at a whopping $185 per share – well above its already-elevated range – raising a staggering $5.55 billion and landing a fully diluted valuation of about $56 billion.

That makes it the largest initial public offering of 2026 (to date), and one of the biggest US listings in years.

More importantly, Cerebras stock hit $386 – roughly 100% above the offering price- and while this pop may deter some, long-term investors have ample reasons to gain exposure as CBRS debuts on May 14.

What differentiates Cerebras stock in the semiconductor sector

At the heart of the Cerebras story is a piece of hardware unlike anything the semiconductor industry has produced before.

The company’s Wafer-Scale Engine (WSE-3) is not a chip in the conventional sense – it is an entire silicon wafer engineered into a single processor, making it about 58x larger than Nvidia’s flagship GPU die.

As CEO Andrew Feldman put it on Thursday morning: “We built a chip the size of a dinner plate. In AI, bigger cores win.”

That size advantage translates into extraordinary real-world performance.

Since all the processing cores and memory sit on a single silicon, data travels at near-zero latency – no waiting for signals to hop between chips in a cluster, no coordination overhead.

For inference workloads, the stage of AI where a model actually generates its response, this matters enormously.

In short, CBRS stock is positioned specifically as a low-latency inference specialist, targeting the precise bottleneck that is becoming the dominant cost center in AI deployment.

That is not a niche. As AI usage scales from millions of queries to billions, inference efficiency is the game-changing variable.

Tier-one customers are writing billion-dollar checks

OpenAI has signed a 750-megawatt, multi-year compute deal with Cerebras, one of the largest AI infrastructure contracts ever publicly disclosed.

The AI research lab has already launched its first AI model running entirely on CBRS software – and Sachin Katti, its chief of infrastructure, recently described Cerebras as “dedicated low-latency solution.”

Total commercial commitment from OpenAI exceeds $20 billion, a figure that offers exceptional revenue predictability for a company of this age.

And OpenAI is not alone. In March, Amazon Web Services announced plans to integrate Cerebras CS-3 systems into its data centers, making the chips accessible to enterprise customers via Amazon Bedrock.

That partnership doesn’t just add revenue – it supercharges Cerebras’ distribution reach overnight.

Meanwhile, reports surfaced this week that both Arm and SoftBank attempted to acquire Cerebras ahead of the IPO, a bid the company turned down.

Given strategic buyers are knocking, and the world’s most important AI lab is signing nine-figure compute contracts, the market is sending a clear signal about the credibility of the technology, and what potentially lies ahead for Cerebras shares.

Why valuation isn’t a concern for CBRS shares

Skeptics may point to valuation concerns, but the company’s financials are hard to dismiss.

Cerebras generated $510 million in revenue last year, up 76% year-on-year, on $238 million in net income, representing a 47% net margin – a figure most hardware firms only dream of.

CBRS was oversubscribed by about 20 times during its roadshow, forcing management to raise its price range twice before ultimately pricing above the final range.

The IPO fundraise ($5.55 billion) gives Cerebras a substantial war chest to invest in manufacturing capacity, software development, and customer diversification – the last of which remains the most legitimate investor concern.

Two UAE-affiliated customers, G42 and Mohamed bin Zayed University of Artificial Intelligence, together accounted for 86% of 2025 revenue, a concentration risk that is real and worth monitoring.

That said, the OpenAI and AWS relationships represent a structural shift in that customer mix.

As those contracts ramp through the next two years, the sales base is expected to broaden notably. For investors with a multi-year horizon, today’s debut likely marks the start of a very significant public-markets story.

The post Should you invest in Cerebras stock as it surges 100% on Nasdaq debut? appeared first on Invezz